Epidemiological profile and clinical characteristics of 491 Brazilian patients with neurofibromatosis type 1-Reference-Cited by-同舟云学术

Epidemiological profile and clinical characteristics of 491 Brazilian patients with neurofibromatosis type 1

Published:2022-05-04 Issue:6 Volume:12 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain and Behavior

Author:

Darrigo Junior Luiz Guilherme¹^ORCID,Ferraz Victor Evangelista de Faria²,Cormedi Marina Candido Visontai²,Araujo Luissa Hikari Hayashi²,Magalhães Mariana Prado Silva³,Carneiro Rafaella Curis³,Sales Luis Henrique Nunes³,Suchmacher Mendel³,Cunha Karin Soares⁴,Filho Aguinaldo Bonalumi⁵,Azulay David Rubem⁶,Geller Mauro³⁷

Affiliation:

1. Departament of Pediatrics Ribeirão Preto Medical School University of São Paulo São Paulo São Paulo Brazil

2. Departament of Genetics Ribeirão Preto Medical School University of São Paulo São Paulo São Paulo Brazil

3. Immunology Department Fundação Educacional Serra dos Órgãos (UNIFESO), Rio de Janeiro Rio de Janeiro Brazil

4. Department of Pathology and Post‐graduation Program in Pathology School of Medicine Fluminense Federal University, Rio de Janeiro Rio de Janeiro Brazil

5. Hospital Naval Marcilio Dias (HNMD), Rio de Janeiro Rio de Janeiro Brazil

6. Dermatology Service Prof. Rubem David Azulay Dermatology Institute, Rio de Janeiro Rio de Janeiro Brazil

7. Clinical Immunology Instituto de Pós‐Graduação Médica Carlos Chagas (IPGMCC), Rio de Janeiro Rio de Janeiro Brazil

Publisher

Wiley

Subject

Behavioral Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2599

Reference43 articles.

1. Neurofibromatosis: part 2 – clinical management

2. The RASopathies as an example of RAS/MAPK pathway disturbances: clinical presentation and molecular pathogenesis of selected syndromes;Bezniakow N.;Developmental Period Medicine,2014

3. Neurofibromatosis Type 1 in a Pediatric Population: Ste-Justine's Experience

4. FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

5. Prevalência de neurofibromas plexiformes em crianças e adolescentes com neurofibromatose tipo 1

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent discoveries of Sino-Caucasian differences in the genetics of phaeochromocytomas and paragangliomas;Best Practice & Research Clinical Endocrinology & Metabolism;2024-08

2. Giant cell granuloma and neurofibroma in the mandible of a patient with neurofibromatosis type 1: a long-term follow-up case report with radiological and surgical aspects and a review of the literature;BMC Oral Health;2024-07-14

3. A life-threatening, massive subcutaneous hematoma caused by trauma in a patient with neurofibromatosis type 1: a case report and literature review;Frontiers in Oncology;2024-05-31

4. A Systematic Review of Diagnostic Modalities and Strategies for the Assessment of Complications in Adult Patients with Neurofibromatosis Type 1;Cancers;2024-03-11

5. Real-world Settings for the Surgical Treatment of Neurofibroma in Patients with Neurofibromatosis Type 1;JMA Journal;2024